Aoyama Renacel Clinic Develops Unique Hair Regeneration Treatment Powerful Blood Flow Improvement Effect Simultaneously Resolves AGA and ED

Aoyama Renacell Clinic (3F Aoyama NA Building, 2-7-28 Kita-Aoyama, Minato-ku, Tokyo) has submitted a Type 2 Regenerative Medicine Plan "Treatment for Alopecia using Autologous Adipose-Derived Mesenchymal Stem Cells" for thinning hair and alopecia including AGA to the Ministry of Health, Labor and Welfare, which has been accepted (Plan (Plan number: PB3240320).

As a regenerative medicine clinic specializing in stem cell therapy for diabetes, ED, skin regeneration, knee joints, etc., the clinic has already submitted a total of 10 plans for providing regenerative medicine using stem cells, and will have approximately 250 cases of stem cell therapy in FY2024.

The clinic promotes total systemic disease control and rejuvenation therapy using a combination of stem cells and our original culture supernatant solution, aiming to control systemic diseases such as diabetes and arteriosclerosis through intravenous infusion therapy while simultaneously improving facial wrinkles and sagging skin and restoring male function through local injection.

This "Value Plan" package has been very well received by our patients, and in response to strong requests for not only skin aging and ED, but also hair regeneration, we have now succeeded in developing a unique treatment protocol and have decided to begin offering it.

The supernatant solution of deciduous dental pulp-derived stem cell culture produced at our CPC has been our signature product since the clinic opened in 2020, and we have been maintaining a monthly treatment volume of 2,000 ml, This supernatant solution has been proven to contain dozens of times more VEGF (vascular endothelial growth factor), which is essential for hair regeneration, than ordinary culture supernatant solution, according to measurements by a highly reliable external testing laboratory.

By simultaneously transplanting our original VEGF culture supernatant solution and stem cells extracted and cultured from the patient's own body into the scalp, a powerful effect of improving blood flow is produced, safely promoting hair regeneration without the risk of side effects.

AGA (male pattern baldness), a major disorder of thinning hair and alopecia, is caused by DHT (dihydrotestosterone), a metabolic product of male hormones.

However, as a result of inhibiting the DHT-producing effects of male hormones, the development of ED, such as decreased male function and libido, has been reported as a side effect, posing a serious dilemma for male patients.

The AGA regeneration therapy developed by our clinic does not use these drugs, so there is no need to worry about side effects, and the local injection of stem cells and VEGF culture supernatant solution into the scalp and penile corpus cavernosum enables simultaneous improvement of AGA and ED, as well as control of systemic diseases through the combined use of intravenous therapy.

The regenerative medicine plan accepted by the Ministry of Health, Labour and Welfare includes not only AGA, but also female pattern baldness (thinning hair and hair loss in women) and alopecia areata.

Company Profile

Company name: Aoyama Renacelle Clinic, Incorporated Association

Representative Director: Taro Tsuchiya

Location: Aoyama NA Bldg. 3F, 2-7-28 Kita-Aoyama, Minato-ku, Tokyo

Establishment : May 21, 2020

Business: Operation of regenerative medicine clinics

URL ： https://rena-cell.com